Grace Therapeutics, Inc.

Pharmaceutical company · Princeton, New Jersey, United States · Nasdaq: GRCE

Grace Therapeutics, Inc. is a pharmaceutical company headquartered in Princeton, New Jersey, United States. Its shares trade on Nasdaq under the ticker GRCE. It has reported private securities offerings to the US SEC, most recently $15 million sold in a notice filed in 2025.

Profile compiled from public records. Is this your company? Request a correction or update

Grace Therapeutics at a glance

Typepharmaceutical company

HeadquartersPrinceton, New Jersey, United States

Stock listingNasdaq: GRCE

SEC industryPharmaceutical Preparations

SEC CIK1444192

What does Grace Therapeutics do?

Private fundraising reported to the SEC

4 Form D notices; the most recent reported $15 million sold (2025).

Frequently asked questions about Grace Therapeutics

Where is Grace Therapeutics headquartered?

Grace Therapeutics, Inc. is headquartered in Princeton, New Jersey, United States.

What does Grace Therapeutics do?

Grace Therapeutics, Inc. is a pharmaceutical company. Its SEC industry classification is Pharmaceutical Preparations.

Is Grace Therapeutics a public company?

Yes. Grace Therapeutics, Inc. trades on Nasdaq under the ticker GRCE.

Similar companies

Soligenix, Inc.Princeton, New Jersey, United States
PDS Biotechnology CorpPrinceton, New Jersey, United States
Enalare Therapeutics Inc.Princeton, New Jersey, United States
Amicus Therapeutics, Inc.Princeton, New Jersey, United States
Bristol Myers Squibb CoPrinceton, New Jersey, United States
PMV Pharmaceuticals, Inc.Princeton, New Jersey, United States
AbbVie Inc.North Chicago, Illinois, United States
Savara IncAustin, Texas, United States

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.